عنوان
پدید آورنده
موضوع
رده
کتابخانه
محل استقرار
LA2qn1p4bz
انگلیسی
The successful treatment with ixekizumab in a multi-failure psoriasis patient
[Article]
Azevedo, Alexandra; Torres, Tiago
We report a patient with severe psoriasis who failed to respond to phototherapy, conventional systemic treatment and four biologic agents (etanercept, ustekinumab, adalimumab and secukinumab). Combination of a higher-dose secukinumab regimen with phototherapy had no success. Remarkably, ixekizumab, an IL-17A inhibitor, provided almost complete psoriasis clearance after 24 weeks of treatment. The reason for the success of ixekizumab after the failure to respond to a biologic with same mechanism of action is still unknown. Interestingly, failure of secukinumab does not preclude future therapeutic success with a second IL-17A-inhibitor.
2018
Dermatology Online Journal
24/9
Azevedo, Alexandra; Torres, Tiago
مطالعه متن کتاب [Article]
275578
a
Y
